Form D Explorer

Form C/A — Polaryx Therapeutics, Inc.

0001213900-25-094743 · filed 2025-10-01 · via DEALMAKER SECURITIES LLC

Offering

Target: $15,000
Maximum: $4,999,999
Security type: Common Stock
Price per security: $0.7000
Deadline: —
Oversubscription: Accepted

Issuer

Name: Polaryx Therapeutics, Inc.
CIK: 2075320
Entity: Corporation
Jurisdiction: WY
Address: South Tower, 140 E Ridgewood Avenue
Paramus, NJ 07652
Phone: —

Most recent fiscal year financials

Total assets

$5,001,000

Cash

—

Short-term debt

—

Long-term debt

—

Revenues

—

COGS

—

Taxes paid

—

Net income

$-30,356,000

View original on SEC EDGAR.